FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Emilie Thivat

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Zuzana Tatar; Emilie Thivat; Catherine Abrial; Emilie Gadea; Pierre Gimbergues; Eloise Planchat; Xavier Durando
Temozolomide and unusual indications: review of literature.
Emilie Thivat; Isabelle Van Praagh; A Belliere; Philippe Chollet; A F Dillies; Xavier Durando; Fabrice Kwiatkowski; H Mahammedi; Marie-Ange Mouret-Reynier; R Chevrier
Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors.
Xavier Durando; Pierre Gimbergues; Nicolas Magné; Sandrine Mansard; Laura Brocard; Amaury Daste; Emilie Thivat
[Therapeutic strategies and systemic treatment of brain melanoma metastases].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Emilie Thivat (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Zuzana Tatar; Emilie Thivat; Catherine Abrial; Emilie Gadea; Pierre Gimbergues; Eloise Planchat; Xavier Durando
Temozolomide and unusual indications: review of literature.
Cancer treatment reviews 2013;39(2):125-35.
2013: Emilie Thivat; Isabelle Van Praagh; A Belliere; Philippe Chollet; A F Dillies; Xavier Durando; Fabrice Kwiatkowski; H Mahammedi; Marie-Ange Mouret-Reynier; R Chevrier
Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors.
Oncology 2013;84(2):67-74.
2013: Xavier Durando; Pierre Gimbergues; Nicolas Magné; Sandrine Mansard; Laura Brocard; Amaury Daste; Emilie Thivat
[Therapeutic strategies and systemic treatment of brain melanoma metastases].
Bulletin du cancer 2013;100(1):23-8.
2012: Marie-Chantal Farges; Régine Minet-Quinard; Josep Ribalta; Edmond Rock; Emilie Thivat; Stéphane Walrand; Brigitte Winklhofer-Roob; Marie-Paule Vasson
Immune status is more affected by age than by carotenoid depletion-repletion in healthy human subjects.
The British journal of nutrition 2012;108(11):2054-65.
2012: E Gadéa; B Morio; E Planchat; Emilie Thivat; Xavier Durando
Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms.
Obesity reviews : an official journal of the International Association for the Study of Obesity 2012;13(4):368-80.
2011: E Planchat; Christophe Pomel; Emilie Thivat; Q Wang-Lopez; Catherine Abrial; P Chollet; Fabrice Kwiatkowski; Marie-Ange Mouret-Reynier; Jean-Marc Nabholtz; Xavier Durando
Late lines of treatment benefit survival in metastatic breast cancer in current practice?
Breast (Edinburgh, Scotland) 2011;20(6):574-8.
2011: E Planchat; Christophe Pomel; Emilie Thivat; Catherine Abrial; Philippe Chollet; Xavier Durando; Jean-Pierre Ferrière; Fabrice Kwiatkowski; Marie-Ange Mouret-Reynier; Jean-Marc Nabholtz
Prognostic value of initial tumor parameters after metastatic relapse.
Cancer investigation 2011;29(9):635-43.
2010: Olivier Gilliot; Xavier Durando; Catherine Abrial; Aurélie Bellière; Pierre Gimbergues; Emilie Thivat; Eloïse Planchat; Michel Lapeyre; Fabrice Kwiatkowski; Ivan Toledano; Philippe Chollet; Jean-Marc Nabholtz; Pierre Verrelle
Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?
Cancer investigation 2010;28(2):195-200.
2010: Régine Minet-Quinard; M Chantal Farges; Emilie Thivat; Cécile Deleine; Gilles Mayot; Julius Brtko; Josep Ribalta; Brigitte Winklhofer-Roob; Edmond Rock; M Paule Vasson
Neutrophils are immune cells preferentially targeted by retinoic acid in elderly subjects.
Immunity & ageing : I & A 2010;7():10.
2010: Xavier Durando; Marie-Chantal Farges; Emmanuel Buc; Catherine Abrial; Caroline Petorin-Lesens; Brigitte Gillet; Marie-Paule Vasson; Denis Pezet; Philippe Chollet; Emilie Thivat
Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.
Oncology 2010;78(3-4):205-9.
2009: Emilie Thivat; Marie-Chantal Farges; Franck Bacin; Michel D'Incan; Marie-Ange Mouret-Reynier; Eric Cellarier; Jean-Claude Madelmont; Marie-Paule Vasson; Philippe Chollet; Xavier Durando
Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma.
Anticancer research 2009;29(12):5235-40.
2009: Laurent Poincloux; Xavier Durando; Jean François Seitz; Emilie Thivat; Valérie-Jeanne Bardou; Marie-Hélène Giovannini; Danièle Parriaux; Nicolas Barriere; Marc Giovannini; Jean-Robert Delpero; Geneviève Monges
Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
Surgical oncology 2009;18(4):357-65.
2009: Catherine Abrial; Xavier Durando; Marie-Ange Mouret-Reynier; Emilie Thivat; Mathilde Bayet-Robert; Béatrice Nayl; Pascale Dubray; Christophe Pomel; Philippe Chollet; F Penault-Llorca
Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials.
International journal of general medicine 2009;2():129-40.
2009: Samuel Guénin; Daniel Morvan; Emilie Thivat; Georges Stepien; Aicha Demidem
Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming.
Nutrition and cancer 2009;61(4):518-29.
2009: Olivier Tacca; Marianne Leheurteur; Xavier Durando; Marie-Ange Mouret-Reynier; Catherine Abrial; Emilie Thivat; Mathilde Bayet-Robert; Frédérique Penault-Llorca; Philippe Chollet
Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?
Cancer investigation 2009;27(1):81-5.
2008: Frédérique Penault-Llorca; Catherine Abrial; Inès Raoelfils; Philippe Chollet; Anne Cayre; Marie-Ange Mouret-Reynier; Emilie Thivat; Florence Mishellany; Pierre Gimbergues; Xavier Durando
Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.
The oncologist 2008;13(12):1235-45.
2008: Gaëlle Montmayeur; Emilie Thivat; Pierre Gimbergues; Malek Dib; Marianne Leheurteur; Hervé Curé; Philippe Chollet; Xavier Durando
[Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics].
Gastroentérologie clinique et biologique 2008;32(10):874-5.
2008: Catherine Abrial; Emilie Thivat; Olivier Tacca; Xavier Durando; Marie-Ange Mouret-Reynier; Pierre Gimbergues; Frédérique Penault-Llorca; Philippe Chollet
Measurement of residual disease after neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3094; author reply 3095.
2008: Philippe Chollet; Catherine Abrial; Xavier Durando; Emilie Thivat; Olivier Tacca; Marie-Ange Mouret-Reynier; Marianne Leheurteur; Fabrice Kwiatkowski; Jacques Dauplat; Frédérique Penault-Llorc
A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN).
Cancer journal (Sudbury, Mass.) 2008;14(2):128-32.
2008: Xavier Durando; Emilie Thivat; Marie-Chantal Farges; Eric Cellarier; Michel D'Incan; Aïcha Demidem; Marie-Paule Vasson; Chantal BARTHOMEUF; Philippe Chollet
Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial.
Nutrition and cancer 2008;60(1):23-30.
2008: Xavier Durando; Emilie Thivat; Pierre Gimbergues; Eric Cellarier; Catherine Abrial; Mathilde Dib; Olivier Tacca; Philippe Chollet
[Methionine dependency of cancer cells: a new therapeutic approach?].
Bulletin du cancer 2008;95(1):69-76.
2007: Xavier Durando; Emilie Thivat; Olivier Gilliot; Bernard Irthum; Pierre Verrelle; Catherine Vincent; Jacques-Olivier Bay
Temozolomide treatment of an adult with a relapsing medulloblastoma.
Cancer investigation 2007;25(6):470-5.
2007: Emilie Thivat; Xavier Durando; Aicha Demidem; Marie-Chantal Farges; Maryse Rapp; Eric Cellarier; Samuel Guenin; Michel D'Incan; Marie-Paule Vasson; Philippe Chollet
A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer.
Anticancer research 2007;27(4C):2779-83.
2006: Xavier Durando; Emilie Thivat; Henri Roché; Jacques-Olivier Bay; Jean-Jacques Lemaire; Pierre Verrelle; M-A Lentz; Jean Chazal; Hervé Curé; Philippe Chollet
Cystemustine in recurrent high grade glioma.
Journal of neuro-oncology 2006;79(1):33-7.
2005: Emilie Thivat; Xavier Durando; Michel D'Incan; Hervé Cure; Marie-Ange Mouret-Reynier; Jean-Claude Madelmont; Pierre Souteyrand; Philippe Chollet
Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial.
Anti-cancer drugs 2005;16(9):1003-7.
2005: Xavier Durando; Emilie Thivat; Michel D'Incan; Anne Sinsard; Jean-Claude Madelmont; Philippe Chollet
Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.
BMC cancer 2005;5():147.